Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. (Q34186679)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. |
scientific article |
Statements
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia (English)
Jorge Nieva
27 March 2003